» Articles » PMID: 19181342

Choice of Hemostatic Agent Influences Adhesion Formation in a Rat Cecal Adhesion Model

Overview
Journal J Surg Res
Specialty General Surgery
Date 2009 Feb 3
PMID 19181342
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hemostatic agents are frequently used during abdominal surgery and some are linked to adhesion formation. We sought to evaluate the impact of several commonly used hemostatic agents on adhesion formation in a rat peritoneal model.

Methods: In our study, Wister outbred rats underwent laparotomy and excision of a portion of their peritoneum to initiate adhesion formation process. One of six different hemostatic agents, namely, activated starch microspheres (Arista AH; Medafor Inc., Minneapolis, MN), glutaraldehyde activated collagen (BioGlue; Cryolife Inc., Kennesaw, GA), thrombin coated collagen microspheres (FloSeal; Baxter Inc., Deerfield, IL), thrombin activated fibrin polymer (Tisseel, Baxter), polyethylene glycol polymer (CoSeal, Baxter), or oxidized cellulose (Surgicel; Ethicon Inc., Somerville, NJ), was placed in the area of peritoneal defect. All animals were sacrificed on post-op day 7 and strength and extent of adhesion formation was determined. Histopathological examination of rat caecum was also performed.

Results: Arista and CoSeal showed significantly lower adhesion formation than controls (P < 0.05). Higher adhesion scores were seen in BioGlue (P < 0.05) treated rats. Additionally, histopathologic examination showed that BioGlue caused statistically more inflammation and necrosis than controls (P < 0.05). Total adhesion score increased with residual amount of agent present at 7 d.

Conclusions: Use of Arista and CoSeal may help in reducing peritoneal adhesions after intra-abdominal surgeries. Furthermore, there appears to be a relationship between the creation of inflammation and necrosis in tissues and the eventual formation of adhesions. This could aid in improving the design of these agents in the future.

Citing Articles

Review of Evidence Supporting the Arista™ Absorbable Powder Hemostat.

LyBarger K Med Devices (Auckl). 2024; 17:173-188.

PMID: 38800552 PMC: 11127658. DOI: 10.2147/MDER.S442944.


TAVAC: comprehensive review of currently available hemostatic products as adjunct to surgical hemostasis.

Sucandy I, Ross S, DeLong J, Tran M, Qafiti F, Pechman D Surg Endosc. 2024; 38(5):2331-2343.

PMID: 38630180 DOI: 10.1007/s00464-024-10806-x.


Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField PH, HaemoCer™ PLUS and StarSil in the Optimized Peritoneal Adhesion Model.

Poehnert D, Neubert L, Winny M Int J Med Sci. 2024; 21(3):424-430.

PMID: 38250612 PMC: 10797680. DOI: 10.7150/ijms.90024.


Development of a bleeding scale and hemostasis algorithm in cranial neurosurgery.

Eyupoglu I, Tuettenberg J, Schebesch K, Buhl R, Hampl J, Kiriyanthan G Heliyon. 2023; 9(12):e22806.

PMID: 38076114 PMC: 10704223. DOI: 10.1016/j.heliyon.2023.e22806.


Experimental evaluation of the use of starch and carboxymethylcellulose in the prevention of intraperitoneal adhesions in hernia surgery with coated meshes.

Santos Filho P, Hirano E Acta Cir Bras. 2023; 38:e383323.

PMID: 37729350 PMC: 10508194. DOI: 10.1590/acb383323.